Claims for Patent: 8,547,248

Summary for Patent: 8,547,248

Title:	Implantable zero-wire communications system
Abstract:	The present invention provides implantable systems that communicate wirelessly with each other using a unique format that enables devices configurations and applications heretofore not possible. Embodiments of the present invention provide communication apparatuses and methods for exchanging information with implantable medical devices. In some embodiments, two implantable devices communicate with each other using quasi-electrostatic signal transmission in a long wavelength/low frequency electromagnetic band, with the patient's body acting as a conductive medium.
Inventor(s):	Zdeblick; Mark J. (Portola Valley, CA), Robertson; Timothy (Belmont, CA)
Assignee:	Proteus Digital Health, Inc. (Redwood City, CA)
Application Number:	12/063,095
Patent Claims:	1. A system for communicating information within a body of a patient, the system comprising: (a) a first device comprising a transmitter configured to transmit a quasi-electrostatic signal via a quasi-electrostatic coupling to the body of the patient; and (b) a second device comprising a receiver configured to receive the transmitted quasi-electrostatic signal via a quasi-electrostatic coupling to the body of the patient; wherein the quasi-electrostatic signal is transmitted between the first and second device within the body of the patient and wherein the body of the patient is the conducting medium for the quasi-electrostatic signal. 2. The system according to claim 1, wherein said system includes at least a third device which is configured to at least one of: (i) transmit a quasi-electrostatic signal via a quasi electrostatic coupling to the body of the patient; and (ii) receive the transmitted quasi-electrostatic signal via a quasi electrostatic coupling to the body of the patient wherein the quasi-electrostatic signal is transmitted between the first and second device within the body of the patient and wherein the body of the patient is the conducting medium for the quasi-electrostatic signal; wherein the quasi-electrostatic signal is transmitted and received by the third device within the body of the patient and wherein the body of the patient is the conducting medium for the quasi-electrostatic signal. 3. The system according to claim 1, wherein said quasi-electrostatic signal comprises data produced by said first device. 4. The system according to claim 1, wherein said quasi-electrostatic signal comprises an identifier of said first device. 5. The system according to claim 1, wherein said quasi-electrostatic signal is used by said second device as a power source. 6. The system according to claim 1, wherein said first device is an implantable medical device. 7. The system according to claim 6, wherein said first device includes a sensor. 8. The system according to claim 7, wherein said sensor is a blood flow sensor. 9. The system according to claim 8, wherein said blood flow sensor comprises a resistivity sensor. 10. The system according to claim 8, wherein said blood flow sensor comprises an electromagnetic blood flow sensor. 11. The system according to claim 6, wherein said first device includes an effector. 12. The system according to claim 11, wherein said effector comprises an electrode. 13. The system according to claim 1, wherein the first device comprises an ingestible medical device. 14. The system according to claim 1, wherein the first device is an external device configured to contact a surface of the body of the patient and is capable of detecting and/or generating the quasi-electrostatic signal through the skin of the body of the patient. 15. The system according to claim 1, wherein the second device is an implantable medical device. 16. The system according to claim 15, wherein the second device is further configured to retransmit the received signal to a secondary receiver external to said patient. 17. The system according to claim 16, wherein said secondary receiver further comprises a radio frequency (RF) receiver and RF transmitter. 18. The system according to claim 16, wherein said second device includes a transcutaneous wire configured to retransmit the received information to the secondary receiver. 19. The system according to claim 16, wherein said secondary receiver is internal to said patient. 20. The system according to claim 1, wherein the second device is a pacemaker. 21. A communications device for use within a body of a patient, said communications device comprising: (a) a power supply; (b) a signal generating circuit coupled to said power supply and configured to generate a quasi-electrostatic signal; and (c) an antenna coupled to said signal generating circuit and configured to transmit said quasi-electrostatic signal via quasi-electrostatic coupling to said body; wherein the quasi-electrostatic signal is transmitted from said antenna within the body of the patient and wherein the body of the patient is the conducting medium for the quasi-electrostatic signal. 22. The communications device according to claim 21, wherein said power supply comprises a battery. 23. The communications device according to claim 21, wherein said power supply comprises: (i) an antenna configured to receive energy from an energy source via a quasi-electrostatic coupling to said body; and (ii) a converter circuit configured to convert the received energy to electrical power. 24. The communications device according to claim 21, wherein said antenna comprises a pair of electrodes separated by a gap. 25. The communications device according to claim 21, wherein said signal generating circuit is further configured to generate a quasi-electrostatic signal representing information. 26. The communications device according to claim 25, wherein said signal generating circuit comprises an oscillator coupled to said antenna. 27. The communications device according to claim 26, wherein said oscillator is configured to operate at a frequency such that a radiation field generated by the antenna has a wavelength more than 10 times longer than a largest dimension of said body. 28. The communications device according to claim 27, wherein said oscillator is configured to operate at a frequency of about 10 MHz or less. 29. The communications device according to claim 28, wherein said oscillator is configured to operate at a frequency of between about 300 Hz and about 1 MHz. 30. The communications device according to claim 21, wherein said signal generating circuit comprises: (i) a driver coupled to drive a time varying potential on said antenna; (ii) an oscillator having an output coupled to said driver; and (iii) a modulator configured to modulate a frequency of the oscillator output so as to encode the information. 31. The communications device according to claim 21, wherein said signal generating circuit comprises: (i) a driver coupled to drive a time varying potential on said antenna; (ii) an oscillator having an output coupled to said driver; and (ii) a modulator configured to modulate a phase of said oscillator output so as to encode the information. 32. The communications device according to claim 21, wherein said signal generating circuit includes: (i) a driver coupled to drive a time varying potential on said antenna; (ii) an oscillator having an output coupled to said driver; and (iii) a modulator configured to modulate an amplitude of said oscillator output so as to encode the information. 33. The communications device according to claim 21, wherein device is an implantable medical device. 34. The communications device according to claim 33, wherein said device includes a sensor. 35. The communications device according to claim 34, wherein said sensor is a blood flow sensor. 36. The communications device according to claim 35, wherein said blood flow sensor comprises a resistivity sensor. 37. The communications device according to claim 35, wherein said blood flow sensor comprises an electromagnetic blood flow sensor. 38. The communications device according to claim 33, wherein said device includes an effector. 39. The communications device according to claim 38, wherein said effector comprises an electrode. 40. The communications device according to claim 21, wherein the device is an ingestible medical device. 41. The communications device according to claim 21, wherein said device is a pharmaceutical delivery device. 42. A method for communicating information within a body of a patient, said method comprising: (a) operating a transmitter of a device located within said body to generate a quasi-electrostatic signal; and (b) detecting said quasi electrostatic signal using a receiver; wherein the quasi-electrostatic signal is transmitted from said transmitter within the body of the patient and wherein the body of the patient is the conducting medium for the quasi-electrostatic signal. 43. The method according to claim 42, wherein said receiver is disposed within said body. 44. The method according to claim 42, wherein said receiver is in contact with an external surface of said body. 45. The method according to claim 42, wherein said device is an implantable medical device. 46. The method according to claim 45, wherein said device includes a sensor. 47. The method according to claim 46, wherein said sensor is a blood flow sensor. 48. The method according to claim 47, wherein said blood flow sensor is a resistivity sensor. 49. The method according to claim 47 wherein said blood flow sensor is an electromagnetic blood flow sensor. 50. The method according to claim 45, wherein said device includes an effector. 51. The method according to claim 50, wherein said actuator comprises an electrode. 52. The method according to claim 42, wherein the device is an ingestible medical device. 53. A kit comprising at least one of: (a) a first device comprising a transmitter configured to transmit a signal via a quasi-electrostatic coupling to a body of a patient; and (b) a second device comprising a receiver configured to receive the transmitted signal via a quasi-electrostatic coupling to said body; wherein the quasi-electrostatic signal is transmitted from said transmitter within the body of the patient and wherein the body of the patient is the conducting medium for the quasi-electrostatic signal. 54. The kit according to claim 53, wherein said kit comprises both of said first and second devices.